iRhythm Technologies Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $94.95
- Today's High:
- $100
- Open Price:
- $98
- 52W Low:
- $85.74
- 52W High:
- $160.96
- Prev. Close:
- $100.17
- Volume:
- 361515
Company Statistics
- Market Cap.:
- $3.06 billion
- Book Value:
- 7.328
- Revenue TTM:
- $452.06 million
- Operating Margin TTM:
- -22.16%
- Gross Profit TTM:
- $281.63 million
- Profit Margin:
- -21.95%
- Return on Assets TTM:
- -14.47%
- Return on Equity TTM:
- -42.36%
Company Profile
iRhythm Technologies Inc had its IPO on 2016-10-20 under the ticker symbol IRTC.
The company operates in the Healthcare sector and Medical Devices industry. iRhythm Technologies Inc has a staff strength of 1,793 employees.
Stock update
Shares of iRhythm Technologies Inc opened at $98 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $94.95 - $100, and closed at $96.32.
This is a -3.84% slip from the previous day's closing price.
A total volume of 361,515 shares were traded at the close of the day’s session.
In the last one week, shares of iRhythm Technologies Inc have slipped by -5.96%.
iRhythm Technologies Inc's Key Ratios
iRhythm Technologies Inc has a market cap of $3.06 billion, indicating a price to book ratio of 12.237 and a price to sales ratio of 7.3786.
In the last 12-months iRhythm Technologies Inc’s revenue was $452.06 million with a gross profit of $281.63 million and an EBITDA of $-86682000. The EBITDA ratio measures iRhythm Technologies Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, iRhythm Technologies Inc’s operating margin was -22.16% while its return on assets stood at -14.47% with a return of equity of -42.36%.
In Q2, iRhythm Technologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 21.6%.
iRhythm Technologies Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-3.18 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into iRhythm Technologies Inc’s profitability.
iRhythm Technologies Inc stock is trading at a EV to sales ratio of 7.5062 and a EV to EBITDA ratio of -25.4834. Its price to sales ratio in the trailing 12-months stood at 7.3786.
iRhythm Technologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $429.49 million
- Total Liabilities
- $89.41 million
- Operating Cash Flow
- $9.01 million
- Capital Expenditure
- $9.40 million
- Dividend Payout Ratio
- 0%
iRhythm Technologies Inc ended 2024 with $429.49 million in total assets and $0 in total liabilities. Its intangible assets were valued at $429.49 million while shareholder equity stood at $223.88 million.
iRhythm Technologies Inc ended 2024 with $0 in deferred long-term liabilities, $89.41 million in other current liabilities, 30000.00 in common stock, $-579791000.00 in retained earnings and $862000.00 in goodwill. Its cash balance stood at $61.58 million and cash and short-term investments were $164.74 million. The company’s total short-term debt was $14,099,000 while long-term debt stood at $34.94 million.
iRhythm Technologies Inc’s total current assets stands at $242.14 million while long-term investments were $0 and short-term investments were $103.16 million. Its net receivables were $51.11 million compared to accounts payable of $7.15 million and inventory worth $14.48 million.
In 2024, iRhythm Technologies Inc's operating cash flow was $9.01 million while its capital expenditure stood at $9.40 million.
Comparatively, iRhythm Technologies Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $96.32
- 52-Week High
- $160.96
- 52-Week Low
- $85.74
- Analyst Target Price
- $138.11
iRhythm Technologies Inc stock is currently trading at $96.32 per share. It touched a 52-week high of $160.96 and a 52-week low of $160.96. Analysts tracking the stock have a 12-month average target price of $138.11.
Its 50-day moving average was $104.48 and 200-day moving average was $109.83 The short ratio stood at 5.97 indicating a short percent outstanding of 0%.
Around 70.6% of the company’s stock are held by insiders while 11266.9% are held by institutions.
Frequently Asked Questions About iRhythm Technologies Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company’s Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient’s heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.